The Molecular Medicine Tri-Conference has been and will continue to be a platform in recognizing the potential for new technologies and research in molecular medicine, diagnostics, drug discovery, and drug development that have a pivotal role in mitigating disease, improving access to healthcare, and identifying transformative treatments. The Molecular Medicine Tri-Conference offers a plenary keynote session on Monday from 5:00-6:00pm, Tuesday from 8:00-9:15am, and Wednesday from 8:00-10:00am. Join approximately 1,000 of your colleagues in each of these plenary keynote presentations. These are the only times each day that bring all attendees from all the conference programs together in one room.
MONDAY, MARCH 11 5:00 - 6:00PM
5:15 Biospecimen Donation: Personal Journey of a Family and Genetic Diagnostic Lab Advancing Biomedical Research
Sarah shares the now world-famous story of how she anonymously donated her infant son’s post-mortem tissue for biomedical research to some of the most prestigious scientific facilities in the country, including the University of Pennsylvania. Years later, she tracked down each donation. She met with researchers and scientists who received the donations to learn how they are being studied in cutting-edge research for medical discoveries. One of these research scientists who received her son’s retinas is Dr. Arupa Ganguly. Dr. Ganguly directs the genetic diagnostic lab at the University of Pennsylvania and studies retinoblastoma, a childhood-onset cancer caused by mutations in tumor suppression gene. They will share their experience and perspective on biospecimen donation.
Sarah Gray, Author, A Life Everlasting: The Extraordinary Story of One Boy’s Gift to Medical Science
Arupa Ganguly, PhD, Professor of Genetics, Perelman School of Medicine, University of Pennsylvania
Speaker to be Announced, Rheonix
6:00 Grand Opening Reception in the Exhibit Hall with Poster Viewing and Book Signing*
*Book Signing with Sarah Gray, Author, A Life Everlasting: The Extraordinary Story of One Boy’s Gift to Medical Science
Book will be available for purchase onsite
TUESDAY, MARCH 12 8:00 - 9:15AM
Data Science Enabling Personalized Medicine
Big data and machine learning have the potential to improve health, detecting disease at an earlier stage and personalizing interventions. The key ingredient, some say, is applying algorithms to population-wide datasets. But the question remains: is it enough to train smarter algorithms with broader datasets? What other approaches, diagnostics tools, and technologies do we need to accurately assess a patient’s unique needs and build a personalized intervention? A panel of experts across diagnostics, informatics, and therapeutics from government, academia, integrated health centers, data science, and biopharma will lead a highly interactive exploration of these issues and predict what it will take to realize the role of data science enabling personalized medicine.
Moderator: Marty Tenenbaum, PhD, Founder and Chairman, Cancer Commons; Prominent AI Researcher; Cancer Survivor
Tanya Cashorali, CEO, Founder, TCB Analytics
Gaurav Kaushik, Associate Director, Data Products & Strategy, Foundation Medicine, Inc.
David Smoley, CIO, AstraZeneca
Additional Speakers to be Announced
WEDNESDAY, MARCH 13 8:00 - 10:00AM
Plenary Session Panel: Emerging Technologies and Industry Perspectives
A popular session at Tri-Conference! This panel session will feature a series of short podium presentations on emerging and hot technologies in molecular medicine. Each speaker will have 7 minutes to present. After all speakers have presented, there will be a moderated Q&A with attendees. The presentations are not meant to be a corporate or specific product pitch. Each speaker will focus on a technology and solution framed around a motivational clinical problem and how their particular company/organization is solving it.
Kristin Ciriello Pothier, Global Head of Life Sciences Strategy, Parthenon-EY; Author, Personalizing Precision Medicine
Scott Palmer, Vice President and Head of Precision Medicine, Parthenon-EY
Speaker to be Announced, Protolife
Speaker to be Announced, iSpecimen
Speaker to be Announced, Ximedica
Joseph Krueger, CSO, Flagship Biosciences
Florian Bell, Senior Member, Technical Staff-System Integration, Qorvo Biotechnologies, LLC
Speaker to be Announced, Benchling
Speaker to be Announced, ANGLE plc
Additional Speakers to be Announced
* The program is subject to change without notice, due to unforeseen reason.